Latest Breaking News On - Agencia espanola de medicamentos - Page 1 : comparemela.com

INmune Bio Receives EMA s Authorization in France and Spain for Phase II Clinical Trial of XPro™ for Early Alzheimer s Disease

INmune Bio Receives EMA s Authorization in France and Spain for Phase II Clinical Trial of XPro™ for Early Alzheimer s Disease
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Boca ratonUnited statesUnited kingdomJason nelsonDavid mossMedicamentosy productos sanitariosInmune bioDrug administrationCompany clinical trial applicationCompany current reports on formExchange commissionCompany quarterly reports on formInmune bio incCompany annual report on formEuropean medicines agencyGlobe newswire inmune bio inc

OSE Immunotherapeutics SA: OSE Immunotherapeutics Receives New Approval for an Early Access Program for Tedopi in Spain in Non-Small Cell Lung Cancer After Failure to Immunotherapies

Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE) today announced that the Spanish Drug Agency (Agencia Espanola de Medicamentos y Productos Sanitarios, AEMPS)

France generalComunidad autonoma de catalunaDennis riedlNicolas poirierThomas guillotFlorence portejoieSylvie berrebiNantes university hospitalCancer centerBoehringer ingelheimDrug administrationInternational mediaSpanish health agencyHealth authoritiesEuropean medicines agencyVeloxis pharmaceuticals inc

Stem cell biotech Neuroplast enrolls first patient in Phase II clinical trial of transformative Neuro-Cells treatment for Traumatic Spinal Cord Injury

Neuro-Cells treatment aims to reduce irreversible damage to the central nervous system from secondary inflammation following traumaThe randomized, placebo-controlled, international multi-center

United statesNoord hollandKostenloser wertpapierhandelErik woltersPrnewswire neuroplastAntonio olivieroMedicamentosy productos sanitariosBrightlands agrifood fundNational videnskabsetisk komitNetherlands enterprise agencyDanish medicines agencyDutch ministry of economic affairsTraumatic spinal cord injuryTraumatic brain injuryFrontotemporal dementiaHospital nacional de parapl